The Real Chernobyl: Q&A With a Radiation Exposure Expert
We talked with Lydia Zablotska, MD, PhD, about the real-life health impacts from the disaster portrayed in the HBO miniseries.
University of California San Francisco
Give to UCSF
Displaying 181 - 210 of 437
-
-
Rare disease discovery: Antibodies fighting cancer go on to attack brain
-
Scientists Discover Autoimmune Disease Associated with Testicular Cancer
Using advanced technology, scientists have discovered an autoimmune disease that appears to affect men with testicular cancer.
-
A Decade of Research Sharpens View of Brain Tumor Genetics, Causes
Today, our understanding of glioma subtypes has expanded to include the molecular and genetic variants that can influence a tumor’s development, prognosis, and response to treatment.
-
You Might Have Sunscreen In Your Blood - But Don't Freak Out Just Yet
-
23andMe gene test might falsely reassure some people of breast cancer risk: Study
-
‘Super-Hero’ Stem Cells Survive Radiation to Regrow Muscles
Newly discovered radiation-resistant stem cells are normally rare and inactive (left), but they take on a major role in muscle repair when regular stem cells are damaged by radiation (right). Credit:
-
Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns
-
Cancer-Killing Combination Therapies Unveiled with New Drug-Screening Tool
UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone. Using this
-
Cancer Exports Molecular ‘Saboteurs’ to Remotely Disarm Immune System
Image courtesy of the National Cancer Institute Immunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that until recently would
-
Cancer’s Trick for Dodging the Immune System
-
UCSF Fellow Tackles an Urgent Threat to Women's Health in Kenya
Chemtai Mungo, MD, MPH, is committed to tackling the public health effects of gender inequality and helping to improve cervical cancer screening in Kenya.
-
Common Pain Reliever Can Improve Survival in Head and Neck Cancer
Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UCSF has found.
-
$26 Million ‘Grand Challenge’ Project Will Probe Role of Inflammation in Cancer
UCSF's Thea Tlsty is a winner of the “Grand Challenge” competition sponsored by Cancer Research UK. Her international team will receive $26 million to uncover how chronic inflammation causes cancer.
-
Drug Hobbles Deadly Liver Cancer by Stifling Protein Production
In laboratory experiments, UCSF researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach.
-
Radiation Dose in CT Scans Varies Due to Scanners’ Technical Settings
The amount of radiation that patients are exposed to from CT scans varies widely between institutions and countries, and is largely due to differences in the technical settings of the scanning machines.
-
Prostate Cancer Disparities Greatest in Low-Risk Disease
Study, led by UCSF, raises intriguing questions about whether the biology of low-risk prostate cancer in black men is distinct from that of other ethnicities.
-
Most Popular Science Stories of 2018
From sensory processing disorder to how CRISPR is being explored to bring new treatments to patients, these are the stories that most engaged our readers in 2018.
-
Depression, Anxiety May Take Same Toll on Health as Smoking and Obesity
Anxiety and depression may be leading predictors of conditions ranging from heart disease to headaches, having similar effects as long-established risk factors like smoking and obesity.
-
Cancer Researchers ID ‘Achilles Heel’ of Drug-Resistant Tumors
UCSF scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies.
-
New ‘SLICE’ Tool Can Massively Expand Immune System’s Cancer-Fighting Repertoire
UCSF researchers have devised a CRISPR-based system called SLICE, which will allow scientists to rapidly assess the function of each and every gene in “primary” immune cells.
-
Treating Brain Cancer with Radiation May No Longer Imperil Cognition
Using a mouse model, researchers showed that a drug that temporarily suppresses a key component of the brain’s immune system can prevent radiation-associated cognitive decline.
-
Less Surveillance Needed for Simple Ovarian Cysts
Study found that simple cysts are normal, extremely common and aren’t linked to a higher risk of ovarian cancer. As a result, unless they are symptomatic, simple cysts can be safely ignored.
-
‘Orphan’ RNAs Make Cancer Deadlier, But Potentially Easier to Diagnose
UCSF demonstrates that cancer is a clever engineer, capable of constructing entirely new disease-promoting networks out of raw materials readily available in the cell.
-
With Disease Agnostic Approach, QBI is Accelerating Ambitious Science
The Quantitative Biosciences Institute attracts investigators on the basis of the tools and techniques they employ, rather than the diseases they study.
-
Advanced Skin Cancer Was Once a Death Sentence. Immunotherapy Is Changing That
-
Heated Tobacco Product Claims by Tobacco Industry Scrutinized by UCSF Researchers, Others in Independent Data Review
Claims by the tobacco industry that heated tobacco products (HTPs) are safer than conventional cigarettes are not supported by the industry’s own data and are likely to be misunderstood by consumers.
-
Blood Test ‘Biopsy’ for Kids with Brain Tumors Is Simple, Safe Way to See If Treatment Is Working
A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even before changes are identified on scans.
-
Building a Patchwork Brain to Study Neurological Disease
Scientists at UCSF and Boston Children’s Hospital have developed a new technique for making mice with brains that combine the genetics of two different mouse strains.
-
Talk on ‘Butt Cancer’ Tackles Taboo with Humor to Win 2018 Postdoc Slam
Ten UCSF postdocs competed to explain complex research in simple language – and in three minutes or less – in the third annual Postdoc Slam held Sept. 26.
